KEYWORDS antiviral activity; lipid droplets; lipid metabolism inhibitors; rotavirus Rotaviruses (RVs) are a major cause of acute gastroenteritis in infants and young children worldwide. These viruses infect the villous epithelium of the small intestine. Part of their replication occurs in cytoplasmic inclusion bodies termed viroplasms. Viroplasms and the lipid droplets (LDs) of cellular organelles are known to interact both physically and functionally. Compounds interfering with the homoeostasis of LDs significantly decrease the production of infectious RV progeny. There is considerable scope for more detailed exploration of such compounds as potential antiviral agents for a disease for which at present no specific therapy exists.
Introduction
Globally, rotaviruses (RVs) are a major cause of acute gastroenteritis (AGE) in infants and young children and in the young of a large variety of mammalian and avian species. 1 RV-associated diseases led to nearly half a million deaths of infants and young children in 2008, mainly in countries of sub-Saharan Africa and Southeast Asia. 2 Two live-attenuated RV vaccines, licensed since 2006, are now incorporated into expanded programs on immunization for children in many countries including areas of the developing world. 3 The universal use of RV vaccines has resulted in reduced hospital admissions and outpatient doctors' consultations for RV-associated AGE in numerous settings. 4, 5 In some countries, RV vaccination also has reduced mortality from RV-associated diseases 6, 7 ; in 2012, the estimate of RV-associated deaths worldwide in children aged under 5 years was reduced to approximately 200,000. 8 Despite this promising trend, the clinician facing a patient with severe RV-induced diarrhea has no specific therapy other than supportive measures, and there is no prophylaxis other than vaccination to offer to susceptible contacts. Herein we describe some novel findings about RV replication, which demonstrate a growing theme in microbiology: the role of lipid droplets (LDs) in the lifecycle of various pathogens. The research outcomes raise the possibility of exploiting this characteristic feature and investigating previously unexplored approaches to have better control over a number of important infectious diseases in both humans and other animals.
RV classification
RVs form a genus of the Reoviridae family and are further subdivided into different groups/species (AeH) and types within groups. 9, 10 The RV genome consists of 11 segments of double-stranded RNA (dsRNA) encoding six structural and six nonstructural (NS) proteins. RV types are distinguished by their surface proteins, VP7 and VP4, as G types and P types, respectively. There are at least 27 different G and 37 different P types within Group A RVs, demonstrating the very high degree of diversity of these viruses. 11 More recently, genotypes of all RV RNA segments have been differentiated.
9,11

RV replication
After adsorption onto and entry into susceptible cells in the gut and partial uncoating, RVs produce single-stranded RNA transcripts, which extrude into the cytoplasm and translate into viral proteins. Further viral propagation takes place in cytoplasmic inclusion bodies termed viroplasms, where subviral particles are assembled and viral RNA replication occurs. The RV NS proteins NSP2 and NSP5 are essential for the formation of viroplasms. No viroplasm formation, viral RNA replication, or production of infectious progeny are seen when the expression or functions of either NSP2 or NSP5 are blocked.
12e14 Subviral double-layered particles (DLPs) are released from viroplasms and mature in the cytoplasm to become triple-layered particles (TLPs) infectious virions, which are released by cell lysis or are extruded without immediate cytopathicity. 1 
Interaction of viroplasms with LDs
During studies on RV replication, our laboratory discovered the interaction of viroplasms with cellular LDs. 15 LDs are the principal intracellular storage sites of triacylglycerols, sterol esters, and cholesterol. 16e18 LDs are surrounded by a phospholipid monolayer into which perilipin, adipophilin, and various other cellular proteins are inserted. 17,19e21 It was shown that RV-induced viroplasms interact with LDs physically and functionally. 15 Using confocal microscopy and fluorescence resonance energy transfer, a physical association between viroplasms and LD-associated proteins and lipids was confirmed (Figure 1 ). Furthermore, it was observed that viroplasms recruit LDs from 4 hours to 6 hours postinfection (p.i.) during the later stages of RV replication. 15 However, more detailed mechanisms of the viroplasmeLD interaction remain to be elucidated.
After ultracentrifugation of a detergent-free extract of RV-infected cells with iodixanol gradients it was observed that LD markers such as perilipin A cosediment in low-density fractions (1.11e1.15 g/mL) with viroplasm markers (NSP2 or NSP5) and with a peak of RV dsRNA replicated in viroplasms. By contrast, spiking of uninfected cell extracts with purified RV DLPs did not lead to their cosedimentation with LD markers; instead, the subviral particles remained as sediments at the bottom of the gradient tube. 15 These observations strengthened the evidence for the physical association between viroplasms and LDs. Having shown that LDs are physically involved in the RV replication cycle, the lipidome of RV-infected cells was compared with that of uninfected cells. 22 Iodixanol-gradient fractions were analyzed for 14 different classes of lipids by mass spectroscopy. 22 The concentrations of virtually all classes of lipids were elevated in RV-infected cells compared with uninfected cells. The low-density fractions of iodixanol gradients mentioned earlier contained peak amounts of lipids, which are characteristically enriched in LDs, including ceramide, sphingomyelin, triglycerides, phosphatidylinositol, and phosphatidic acid, the direct precursor of triacylglycerol. 22 This analysis consolidated the observation that viroplasms interact with LDs during RV replication and suggested that beyond a physical association this also had metabolic consequences, which remain to be explored further.
An increase in the lipid content of cells after RV infection was also reported. 23 Kim and Chang 23 showed that activation of the binding of bile acids to their natural farnesoid X receptor (FXR) or FXR stimulation correlated with a reduction of intracellular lipid content and also with a reduction in the replication of RVs in vitro in a dosedependent manner. 23 More recently, it was shown that inhibitors of lipolysis and inhibitors of fatty acids (FAs) transport to the mitochondria decreased RV replication by 94% to 97%, 24 although the underlying mechanisms of action remain to be fully understood.
Decrease of RV replication by compounds interfering with LD homoeostasis
Given the apparent physical and functional interactions between RV replication and LDs, it was particularly interesting to explore whether compounds that affect cellular lipid metabolism and LD homoeostasis interfere with RV replication. The combination of a beta-adrenergic agonist (isoproterenol isoprenaline) and a phosphodiesterase inhibitor [isobutylmethylxanthine (IBMX)] was previously shown to elevate the intracellular level of cyclic adenosine monophosphate, thus leading to the phosphorylation of perilipin A and hormone-dependent lipase, and finally to lipolysis of LDs. 25, 26 Cells treated concurrently with these two compounds at nontoxic concentrations produce significantly fewer and smaller viroplasms upon infection (Figure 2) , less viral dsRNA due to decreased viral RNA replication, and lower titers of infectious RV progeny (Table 1) . Strikingly, the RV-induced cytopathicity was reduced in the isoprenaline/IBMX-treated cells, which indicates that inhibition of RV replication also protected the cells against virus-induced damage. 15 Interference with the intracellular biosynthetic pathways of FAs also decreased RV replication. Triacsin C, an inhibitor of the long-chain acyl-coenzyme A (CoA) synthetase, 27, 28 and its chemical analogs are reported to inhibit RV replication. 15, 29 An inhibitor of FA synthase (C75) 30 suppressed RV replication consistently, although only marginally, 31 probably due to the low chemotherapeutic index of this drug. However, treatment with 5-(tetradecyloxy)-2-furoic acid (TOFA), an inhibitor of acetyl-CoA carboxylase 1 (ACC1), 32 ,33 a rate-limiting enzyme in early FA synthesis, significantly decreased both RV RNA replication and the infectivity titer of RV progeny, with an in vitro chemotherapeutic index of between 5 and 12. 31 This effect was still detectable when TOFA was added to RV-infected cells as late as at 4 hours p.i. Specific small interfering RNA knockdown of ACC1 produced an effect similar to that of chemical ACC1 inhibition. 31 Table 1 presents a comparison of inhibitory effects of different compounds affecting LD homoeostasis on rotavirus replication.
It is thus necessary to identify in more detail which of the cellular genes involved in LD homoeostasis 34e36 will be important for the interaction of LDs with viroplasms, and thus could affect RV replication.
Broader effects of TOFA on RV replication
The CsCl-gradient ultracentrifugation carried out on untreated or TOFA-treated RV-infected cells permits the separation of DLPs noninfectious virions (density 1.38 g/mL) and TLPs infectious virions (density 1.36 g/mL). 37 TOFA treatment caused an approximately twofold reduction in the production of RV DLPs, but a 20-fold reduction in detectable TLPs. 38 This suggests that the blockage of FA synthesis may affect RV replication not only at the steps occurring within viroplasms up to DLP formation, but also at the later steps of viral maturation in the endoplasmic reticulum.
Further research on inhibition of RV replication by LD-disturbing drugs
So far, the involvement of LDs in RV replication has been studied primarily in MA104 cells, a cell line derived from embryonic rhesus monkey kidney and routinely used for RV propagation in vitro. 15 Because RVs replicate in the terminal enterocytes of the epithelium of the small intestine, the interaction of LDs with viroplasms in RV-infected Caco-2 cells, which are derived from clinical specimens of human colon carcinoma, and in RV-infected human liver-derived cells, Huh-7, which have larger LDs than MA104 cells, has been studied, and effects similar to those described earlier were observed. 39 Infection of HT29 cells with RV in the presence of nontoxic concentrations of stilbenoids, cannabinoid receptor antagonists, led to a 10-to 20-fold decrease of the infectivity of RV progeny; one of the suggested mechanisms of action was interference with lipid homoeostasis, because stilbenoids are very lipophilic. 40 Cellular cholesterol was shown to be critical for bovine RV replication in MA104 cells at the stages of viral cell entry and virus assembly. 41 However, more work is needed to explore these interesting observations in-depth. Human intestinal enteroid cultures showed interaction of viroplasms with LDs 42 ( Figure 2H , Ref. 42 , and this will permit further study under more natural pathophysiological conditions. Treatment of mice with compounds decreasing the intracellular triglyceride content led to a reduction of RV shedding on Days 1e3 p.i. when compared with RV-infected, untreated mice. 23 Animal models of RV infection and disease 1 should be explored to find out whether compounds such as isoproterenol þ IBMX and TOFA, which decrease RV production in vitro, will also reduce RV shedding and/or diarrhea. Such studies will be a prerequisite for considering the feasibility and promise of clinical trials in humans.
Potential of LD-disturbing drugs as antivirals
RVs have now joined the growing list of microbes that are dependent on interaction with LDs for their replication, including viruses such as hepatitis C virus (HCV) 43e48 ; dengue virus, 49 GB virus B, a flavivirus 45 ; bunyavirus 50 ; and the intracellular parasites Chlamydia, 51 Mycobacterium tuberculosis, 52 and Mycobacterium leprae. 53 The importance of lipid metabolism for HCV replication has been recognized and this knowledge has been used in the context of successful therapies. 54 On a wider scale, FA biosynthesis has been identified as being an essential step for the replication of a larger number of viruses such as enteroviruses, West Nile virus, human cytomegalovirus, Kaposi sarcoma-associated herpes virus, and Epstein-Barr virus, and lipid metabolic enzymes are considered as potential broad-spectrum drug targets, with some relevant Food and Drug Administration-approved drugs already being available. 55 The importance of LDs for hostepathogen interactions is an emerging theme. 56, 57 There is already proof of principle in vitro and in vivo that compounds perturbing LDs have the potential to become candidate therapeutics for the treatment of RV disease and other microbial diseases. A new and much needed class of antimicrobial drugs may be in waiting.
